Antimicrobial susceptibility and serotypes of Neisseria meningitidis and Streptococcus pneumoniae in Sri Lanka: Experience from the National Reference Laboratory

• 作者: Lilani Karunanayake Veeraraghavan Balaji K.D.N.Gunawardana Rosemol Varghese Vayishnavi Ariram Malka Dassanayake Vaithehi Rajeevan Francis Lakmini Yapa Chamika Herath Nambage Shirani Chandrasiri Priyanka Wimalagunawardhana K.Dhananja Namalie C.T.Hapuarachchi
• 来源期刊: 亚太热带医药杂志（英文版）
• 年，卷（期）: 2022,（3）
• 所属期刊栏目: Original Articles
• 页码范围: 114-120
• 页数: 7页
• 语种: 英文
• DOI: 10.4103/1995-7645.340574

摘要

Objective: To determine the antimicrobial susceptibility and serotypes of Neisseria (N.) meningitidis and Streptococcus (S.) pneumoniae in Sri Lankan patients. Methods: We retrospectively analyzed 11 blood culture specimens from suspected patients with invasive meningococcal disease and 26 S. pneumoniae clinical isolates. We tested 6 antimicrobials against N. meningitidis and 12 antimicrobials against S. pneumoniae. Meningococcal serogroup was determined by realtime PCR and Quellung serotyping was used for pneumococcal analysis. Results: N. meningitidis serogroup B was the most common in this study. Intermediate-susceptibility to penicillin was seen in 75.0％ (6/8) of strains. Susceptibility to ciprofloxacin, levofloxacin and cotrimoxazole was 62.5％ (5/8), 62.5％ (5/8) and 87.5％ (7/8), respectively. Excellent susceptibility was seen in cefotaxime and meropenem. In S. pneumoniae, the most common serotype was 19F in both invasive and non-invasive pneumococcal diseases. The majority of strains showed multidrug resistance. Penicillin non-susceptibility in non-meningeal strains were 13.6％ and all meningeal strains were penicillin resistant. Erythromycin was highly resistant in both groups. Amoxicillin showed excellent susceptibility in non-invasive pneumococcal diseases strains. Linezolid, levofloxacin and vancomycin showed 100.0％ susceptibility in all pneumococcal isolates. Conclusions: Implementation of vaccines should be considered, especially for children and high-risk populations. This may contribute to reducing pneumococcal and meningococcal invasive disease burden and help prevent emergence of antimicrobial resistant strains.